Filtered By:
Condition: Hypertension
Procedure: Heart Valve Surgery

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 173 results found since Jan 2013.

Prognostic value of computer tomography derived measurements of pulmonary artery diameter on long term outcomes after transcatheter aortic valve replacement
CONCLUSION: PAD >29.3 mm in baseline MDCT is associated with higher 1-year mortality after TAVR, independently of echocardiographic measure of PH and frailty.PMID:35892248 | DOI:10.33963/KP.a2022.0173
Source: Kardiologia Polska - July 27, 2022 Category: Cardiology Authors: Łukasz Kalińczuk Zbigniew Chmielak Maciej D ąbrowski Marcin Mazurkiewicz Patrycjusz Stok łosa Wiktor Skotarczak Gary S Mintz Rafa ł Wolny Pawe ł Tyczyński Marek Konka Anna Micha łowska Ilona Kowalik Marcin Demkow Ilona Micha łowska Adam Witkowski Source Type: research

Heart surgery and simultaneous carotid endarterectomy - 10-years single-center experience
CONCLUSION: Within the reported patient population of coronary artery heart disease and significant internal carotid stenosis, a one-time approach with CABG or heart-valve surgery and CEA is safe and feasible as justified by clinical and neurological postoperative outcomes.PMID:35841145 | DOI:10.1177/02676591221114953
Source: Perfusion - July 16, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Stephen Gerfer Borko Ivanov Ihor Krasivskyi Ilija Djordjevic Christopher Gaisendrees Soi Avgeridou Ferdinand Kuhn-R égnier Navid Mader Parwis Rahmanian Axel Kr öner Elmar Kuhn Thorsten Wahlers Source Type: research

Direct Comparison of Outcomes After Transcatheter Aortic Valve Replacement in Veterans and Non-Veterans Using the Transcatheter Valve Therapy Registry
CONCLUSIONS: The affiliation between a VAMC and an academic medical center allowed for direct comparison between veterans and non-veterans undergoing TAVR by the same operators using the TVT registry. Despite significantly higher rates of comorbidities, veterans had equivalent outcomes compared with non-veterans. This may be in part due to the comprehensive care that veterans receive in the VAMC and this institution's integrated heart center team.PMID:35830359
Source: The Journal of Invasive Cardiology - July 13, 2022 Category: Cardiology Authors: Michael A Napolitano Timothy J Holleran Andrew D Sparks Jason R Morrissette Jennifer A DoCampo Federico E Mordini Michael D Greenberg Ramesh Mazhari Jonathan S Reiner Andrew D Choi Joseph Krepp Farzad Najam Elizabeth S Pocock Jared L Antevil Gregory D Tra Source Type: research

Hypertensive response to exercise in adult patients with repaired aortic coarctation
Conclusions A hypertensive response to exercise was present in nearly half of the patients in this large, prospective cohort of adults with repaired CoA. Risk factors for increased peak exercise SBP were male sex, absence of a bicuspid aortic valve and elevated resting SBP. Increased peak exercise SBP independently predicted hypertension at follow-up. These results support close follow-up of patients with a hypertensive response to exercise to ensure timely diagnosis and treatment of future hypertension.
Source: Heart - June 24, 2022 Category: Cardiology Authors: Meijs, T. A., Muller, S. A., Minderhoud, S. C. S., de Winter, R. J., Mulder, B. J. M., van Melle, J. P., Hoendermis, E. S., van Dijk, A. P. J., Zuithoff, N. P. A., Krings, G. J., Doevendans, P. A., Spiering, W., Witsenburg, M., Roos-Hesselink, J. W., van Tags: Congenital heart disease Source Type: research

New Data From Two Large Studies Reinforce Effectiveness of Dual Pathway Inhibition (DPI) with XARELTO ® (rivaroxaban) Plus Aspirin in Patients with Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD)
RARITAN, N.J., May 23, 2022 – Findings from the XARELTO® (rivaroxaban) Phase 3 COMPASS Long-Term Open Label Extension (LTOLE) study and the XARELTO® in Combination with Acetylsalicylic Acid (XATOA) registry have been published in the European Society of Cardiology’s (ESC) European Heart Journal, Cardiovascular Pharmacotherapy. Additionally, the XATOA registry was presented at the American Congress of Cardiology’s 71st Annual Scientific Session (ACC.22). These studies provide further evidence supporting the role of dual pathway inhibition (DPI) with the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 100 mg...
Source: Johnson and Johnson - May 23, 2022 Category: Pharmaceuticals Source Type: news

Low serum albumin: A neglected predictor in patients with cardiovascular disease
Eur J Intern Med. 2022 May 7:S0953-6205(22)00181-9. doi: 10.1016/j.ejim.2022.05.004. Online ahead of print.ABSTRACTAlbumin, the most abundant circulating protein in blood, is an essential protein which binds and transports various drugs and substances, maintains the oncotic pressure of blood and influences the physiological function of the circulatory system. Albumin also has anti-inflammatory, antioxidant, and antithrombotic properties. Evidence supports albumin's role as a strong predictor of cardiovascular (CV) risk in several patient groups. Its protective role extends to those with coronary artery disease, heart failu...
Source: Atherosclerosis - May 10, 2022 Category: Cardiology Authors: Antonis A Manolis Theodora A Manolis Helen Melita Dimitri P Mikhailidis Antonis S Manolis Source Type: research